首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >A novel biocompatible bicephalous dianionic surfactant from oleic acid for solid lipid nanoparticles
【24h】

A novel biocompatible bicephalous dianionic surfactant from oleic acid for solid lipid nanoparticles

机译:一种新型的油酸生物相容性双头双阴离子表面活性剂,用于固体脂质纳米粒

获取原文
获取原文并翻译 | 示例
           

摘要

New biocompatible bicephalous dianionic surfactant with low CMC value was successfully synthesized and its efficacy in pharmaceutical drug delivery system was explored by preparing solid lipid nanoparticles (SLNs) of ketoconazole, a BCS class II drug. Oleic acid based dianionic surfactant was synthesized by attachment of oleic acid through ester linkage, to a bidentate head component, prepared by 1,4-addition of propanolamine and tert-butyl acrylate, followed by hydrolysis and neutralization with sodium bicarbonate. Its critical micelle concentration (CMC), hydrophilic-lipophilic balance and logP_(octanol/water) were found to be 1.6mM/L, 34.68 and -2.96, respectively. Cytotoxicity study, conducted using sulforhodamine B assay, showed LC_(50), GI_(50) and TGI values>80μg/ml indicating its biocompatibility. It was found to be non-irritant by in vivo skin irritation study. The particle size, polydispersity index, and zeta potential of the optimized formulation were 98.2±1.74nm, 0.462±0.016, and -49.6mV, respectively. Further, the SLNs were characterized by scanning electron microscopy, differential scanning calorimetry and X-ray diffraction studies. Drug entrapment efficiency was found to be 87.42±0.31%, and the SLNs exhibited good stability over a period of 3 months. The current investigations, therefore, report the successful development of systematically optimized SLNs of ketoconazole.
机译:成功地合成了具有低CMC值的新型生物相容性双头双阴离子表面活性剂,并通过制备BCS II类药物酮康唑的固体脂质纳米粒(SLN)来探索其在药物给药系统中的功效。通过将油酸通过酯键连接至二齿头部组分,通过将丙醇胺和丙烯酸叔丁酯加成1,4-,然后用碳酸氢钠水解和中和,来合成基于油酸的双阴离子表面活性剂。发现其临界胶束浓度(CMC),亲水-亲脂平衡和logP_(辛醇/水)分别为1.6mM / L,34.68和-2.96。使用磺基若丹明B分析进行的细胞毒性研究显示LC_(50),GI_(50)和TGI值>80μg/ ml,表明其生物相容性。通过体内皮肤刺激性研究发现它没有刺激性。优化配方的粒径,多分散指数和ζ电势分别为98.2±1.74nm,0.462±0.016和-49.6mV。此外,通过扫描电子显微镜,差示扫描量热法和X射线衍射研究来表征SLN。发现药物包封效率为87.42±0.31%,并且SLN在3个月的时间内表现出良好的稳定性。因此,目前的研究报道了酮康唑系统优化的SLN的成功开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号